Literature DB >> 21562470

Nutrition and chronic kidney disease.

Denis Fouque1, Solenne Pelletier, Denise Mafra, Philippe Chauveau.   

Abstract

The incidence of malnutrition disorders in chronic kidney disease (CKD) appears unchanged over time, whereas patient-care and dialysis techniques continue to progress. Despite some evidence for cost-effective treatments, there are numerous caveats to applying these research findings on a daily care basis. There is a sustained generation of data confirming metabolic improvement when patients control their protein intake, even at early stages of CKD. A recent protein-energy wasting nomenclature allows a simpler approach to the diagnosis and causes of malnutrition. During maintenance dialysis, optimal protein and energy intakes have been recently challenged, and there is no longer an indication to control hyperphosphatemia through diet restriction. Recent measurements of energy expenditure in dialysis patients confirm very low physical activity, which affects energy requirements. Finally, inflammation, a common state during CKD, acts on both nutrient intake and catabolism, but is not a contraindication to a nutritional intervention, as patients do respond and improve their survival as well as do noninflamed patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562470     DOI: 10.1038/ki.2011.118

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  44 in total

Review 1.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

2.  Nutrition: Intradialytic oral nutrition--the ultimate conviction.

Authors:  Laetitia Koppe; Denis Fouque
Journal:  Nat Rev Nephrol       Date:  2013-11-19       Impact factor: 28.314

Review 3.  Muscle wasting in chronic kidney disease.

Authors:  Eduardo A Oliveira; Wai W Cheung; Kalodiah G Toma; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2017-05-15       Impact factor: 3.714

4.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

5.  Serum albumin changes and mortality risk of peritoneal dialysis patients.

Authors:  Xiaoxiao Wang; Qingfeng Han; Tao Wang; Wen Tang
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

6.  Gastro-Intestinal Tolerance and Renal Safety of Protein Oral Nutritional Supplements in Nursing Home Residents: A Randomized Controlled Trial.

Authors:  P Ter Wee; M Kuhn; H van der Woude; D Van De Looverbosch; H Heyman; L Mikušová; D Fouque
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

7.  Physical Activity in End-Stage Renal Disease Patients: The Effects of Starting Dialysis in the First 6 Months after the Transition Period.

Authors:  Natascha J H Broers; Remy J H Martens; Tom Cornelis; Frank M van der Sande; Nanda M P Diederen; Marc M H Hermans; Joris J J M Wirtz; Frank Stifft; Constantijn J A M Konings; Tom Dejagere; Bernard Canaud; Peter Wabel; Karel M L Leunissen; Jeroen P Kooman
Journal:  Nephron       Date:  2017-06-08       Impact factor: 2.847

8.  Validity of malnutrition scores for predicting mortality in chronic hemodialysis patients.

Authors:  Flavia R Toledo; Aline A Antunes; Francieli C D Vannini; Liciana V A Silveira; Luis C Martin; Pasqual Barretti; Jacqueline C T Caramori
Journal:  Int Urol Nephrol       Date:  2013-06-21       Impact factor: 2.370

9.  Association of plasma des-acyl ghrelin levels with CKD.

Authors:  Rohit K Gupta; Tamil Kuppusamy; James T Patrie; Bruce Gaylinn; Jianhua Liu; Michael O Thorner; Warren K Bolton
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

10.  Tooth loss strongly associates with malnutrition in chronic kidney disease.

Authors:  E Ioannidou; H Swede; G Fares; J Himmelfarb
Journal:  J Periodontol       Date:  2013-11-11       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.